This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

FDA Authorizes First Wearable to Continuously Monitor Glucose and Ketones

FDA Authorizes First Wearable to Continuously Monitor Glucose and Ketones

The FDA has authorized Abbott’s Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older with diabetes. The...
View All

Latest News and Guidelines

Advanced Diabetes Technologies Alone May Not Eliminate Sociodemographic Disparities in Glycemic Outcomes: Study

Advanced Diabetes Technologies Alone May Not Eliminate Sociodemographic Disparities in Glycemic...

Overcoming the Challenge of Maintaining Weight Reduction

Overcoming the Challenge of Maintaining Weight Reduction

Longer Sitting Time Linked to 9 Percent Higher Risk of Cancer Death: Study

Longer Sitting Time Linked to 9 Percent Higher Risk of Cancer Death: Study

GLP-1 Drugs Linked to Lower Risk of Tuberculosis and Severe Infections: Study

GLP-1 Drugs Linked to Lower Risk of Tuberculosis and Severe Infections: Study

SGLT2i Therapy Improves Survival in Surgical Aortic Valve Patients: Study

SGLT2i Therapy Improves Survival in Surgical Aortic Valve Patients: Study

Always Exhausted? Study Identifies Common Link Across Five Health Conditions

Always Exhausted? Study Identifies Common Link Across Five Health Conditions

View All
X